Early tumour shrinkage (ETS) and its impact on tumour-related symptoms in patients with previously untreated RAS wild-type metastatic colorectal cancer (mCRC): A retrospective analysis of three panitumumab studies

Authors :: Michael Geissler
Julien Taieb
Marc Peeters
Fotios Loupakis
Richard H. Wilson
Fernando Rivera
Timothy J. Price
M. Tracy
Meinolf Karthaus
Peter Burdon
Source :: Annals of Oncology. 29:v96
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Colorectal cancer
Wild type
Hematology
medicine.disease
Internal medicine
medicine
Retrospective analysis
Panitumumab
In patient
business
medicine.drug
Shrinkage

Tools